Hemab Therapeutics Holdings, Inc. (COAG) — 424B4 Filings
All 424B4 filings from Hemab Therapeutics Holdings, Inc.. Browse 1 Prospectus reports with AI-powered summaries and risk analysis.
424B4 Filings (1)
-
Hemab Therapeutics Holdings, Inc. Files 424B4 Prospectus
— May 1, 2026 Risk: medium
Hemab Therapeutics Holdings, Inc. filed a 424B4 prospectus on May 1, 2026, detailing its intention to offer securities. The filing, with SEC Accession No. 00011
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX